Cover
| Cover | May 18, 2023 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | May 18, 2023 |
| Entity File Number | 001-36641 |
| Entity Registrant Name | Brainstorm Cell Therapeutics Inc. |
| Entity Central Index Key | 0001137883 |
| Entity Tax Identification Number | 20-7273918 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 1325 Avenue of Americas |
| Entity Address, Address Line Two | 28th Floor |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10019 |
| City Area Code | 201 |
| Local Phone Number | 488-0460 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.00005 par value |
| Trading Symbol | BCLI |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |